Detalhe da pesquisa
1.
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.
Proc Natl Acad Sci U S A;
121(20): e2322688121, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709925
2.
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.
Mol Cancer Ther;
22(11): 1304-1318, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676980
3.
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.
Cancer Res;
83(19): 3284-3304, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450351
4.
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.
Cancer Res;
82(20): 3673-3686, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950920
5.
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.
Blood Cancer Discov;
3(2): 116-135, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015684
6.
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.
Nat Cell Biol;
23(11): 1187-1198, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737445
7.
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.
Nat Commun;
12(1): 5775, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599169
8.
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.
Cell;
184(21): 5357-5374.e22, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34582788
9.
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.
Nat Cancer;
2(1): 34-48, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33997789
10.
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.
Nat Genet;
53(6): 881-894, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972779
11.
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Nat Commun;
12(1): 1979, 2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785741
12.
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.
Cancer Discov;
11(6): 1524-1541, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589424
13.
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.
Cancer Res;
81(1): 158-173, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158814
14.
Clonal tracing reveals diverse patterns of response to immune checkpoint blockade.
Genome Biol;
21(1): 263, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33059736
15.
ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer.
Cancer Res;
80(21): 4612-4619, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32934023
16.
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
Mol Cell;
78(6): 1096-1113.e8, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416067
17.
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
Cancer Cell;
37(1): 104-122.e12, 2020 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31935369
18.
Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression.
Cell Rep;
25(7): 1898-1911.e5, 2018 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30428356
19.
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.
Science;
359(6377): 770-775, 2018 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301958